Effect of cyclosporin a in a patient with refractory nephrotic syndrome associated with b chronic lymphocytic leukemia

Nephron

Volumn 72, Issue 3, 1996, Pages 468-471

  Eisterer, W ^a   Neyer, U ^b   Hilbe, W ^a   Diem, G ^c   Ohlschlegel C ^d   Ludescher, C ^a   Thaler, J ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b General Hospital Feldkirch   (Austria)

^c Med Specialist in Internal Medicine   (Austria)

^d General Hospital St Gallen   (Switzerland)

Author keywords

B chronic lymphocytic leukemia; Cyclosporin A; Membranous glomerulonephritis; Nephrotic syndrome

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A;

ADULT; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFICACY; FEMALE; HUMAN; LEUKOCYTE COUNT; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA;

BIOPSY; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MIDDLE AGED; NEPHROTIC SYNDROME;

EID: 0030025068     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188915     Document Type: Article

References (27)

1. Gagliano RG. Costanzi JJ. Bcathard GA. Sarles HE, Boll JD: The nephrotic syndrome associated with neoplasia: An unusual paraneoplastic syndrome: Report of a case and review of the literature. Am J Med 1976:60:1026-1031.
2. Seney FD Jr. Federgrcen WR. Stein H. Kash-garian M: A review of nephrotic syndrome associated with chronic lymphocytic leukemia. Arch Intern Med 1986:146:137-141.
3. McLigcvo SO, Notghi A. Thomson D. Ander-ton JL: Nephrotic syndrome associated with chronic lymphocytic leukemia. Nephrol Dial Transplant 1993;8:461-463.
4. Gilboa N, Durante D, Guggenheim S, Lacher J, Holman R. Schorr W. Garfield D. McIntosh RM: Immune deposit nephritis and single-component cryoglobulinemia associated with chronic lymphocytic leukemia. Nephron 1979; 24:223-231.
5. Touchard G. Preud'Hommc JL. Aucouturier P, Giraud C, Gouet D. Yvcr L. Pattc D: Nephrotic syndrome associated with chronic lymphocytic leukemia: An immunological and pathological study. Clin Nephrol 1989:31:107-116.
6. Rostocker G, Belghiti D. Ben Maadi A. Remy P. Lang P. Weil B. Lagrue G: Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 1993:63:335-341.
7. Rostocker G, Toro L. Ben Maadi A. Ryel-lynck J. Sadreux T. Rivalan J. Chevct D. Janin C. Lang P. Weil B. Lagrue G: Cyclosporin in idiopathic steroid resistant membranous glomerulonephritis. Lancet 1989:Vol ii:975-976.
8. Lversen B. and the Norvcgian Kidney register: Cyclosporin A treatment in membranous nephropathy with steroid resistant nephrotic syndrome (abstract). 11th Ini Congr Nephrol. Tokyo, July 1990.
9. Lopez-Gomez J, Jofre R. Gallego E. Perez-Garcia R. Valderrabano F: Cyclosporin A in high risk idiopathic membranous nephropathy (abstract). 11th Ini Congr Nephrol. Tokyo, July 1990.
10. Ponticclli C. Zucchelli P, Passcrini P. Cagnoli L. Cesana B. Pozzi C. Pasquali S. Imbasciati E. Grassi C. Rcdaclli B. Sasdelli M. Locatclli F: A randomized trial of méthylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989;320:8-13.
11. Kibriya MG. Tishkov I. Nikolov D: Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy. Nephrol Dial Transplant 1994:9:138-143.
12. Cameron S. Ogg CS: Nephrotic syndrome in chronic lymphatic leukemia. Br Med J 1974:4: 164.
13. NIH Conference: Membranous nephropathy. Ann Intern Med 1992.116:672-682.
14. Chikkappa G. Pasqualc D. Philips PG. Man-gan KF. Tsan MF: Cyclosporin A for treatment of pure red cell aplasia in patients with chronic lymphocytic leukemia. AmJ Hematol 1987:26: 179-189.
15. Christen R. Morant R. Fehr J: Cyclosporin A therapy of pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia. Eur J Haematol 1989;42:303-307.
16. Larsson R. Jonsson B. Csoka K. Kristenscn J. Nilsson K. Nygren P: Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia. Eur J Pharmacol 1992:228:237-240.
17. Bergui L. Grazia Gregoretti M. Cagliaris-Cap-pio F: Cyclosporin A in the treatment of B-ehronic lymphocytic leukemia (B-CLL). Leukemia 1994:8:1245-1246.
18. Nygren P. Larsson R: Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators. Int J Cancer 1991:48:598-604.
19. Schreiber ST. Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-142.
20. Taniguchi T. Minami Y: The IL-2/1L-2 receptor system: A current overview. Cell 1993;73: 5-8.
21. Lantz O. Grillot-Courvalin C. Schmitt C. Fer-mand JP. Brouet JC: Interleukin 2-induccd proliferation of leukemic human B cells. J Exp Med 1985:161:1225-1230.
22. Giovarelli M, Foa R, Benetton G. Lusso P. Fierro MT. Forni G: Release of interleukins-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization. Leukemia Res 1988:12:201-209.
23. Zietse R. Wenting GJ. Kramer P. Schalekamp MA. Weimar W: Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci 1992:82:641-650.
24. Suranyi MG. Guasch A, Hall BM, Myers BD: Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 1993:21:251-259.
25. O’Garra A, Chang R, Go N, Hastings R. Haughton G. Howard M: Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992, 22:711-717.
26. Youinou P. Mackenzie LE. Lamour A, Magced RA. Lydyard PM: Human CD5-positive Bcells in lymphoid malignancy and connective tissue diseases. EurJ Clin Invest 1993;23:139-150.
27. Icard P. Pelletier L. Vial MC. Mandet C. Pas-quier R. Michel A. Druet P: Evidence fora role of antilaminin-producing B cell clones that escape tolerance in the pathogenesis of HgCl;-indueed membranous glomerulopathy. Nephrol Dial Transplant 1993:8:122-127.